Name: CLARUS THERAPEUTICS HOLDINGS (CRXT) Stock
Brand: CLARUS THERAPEUTICS HOLDINGS
Rating: 3.5 (3 reviews)

CRXT Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder

3 years ago - By: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

3 years ago - By: Benzinga - Mentions: DDI XMTR NOTE STBX ...

Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday

3 years ago - By: InvestorPlace - Mentions: PDD AMC HGEN

Why Is Pinduoduo (PDD) Stock Up 18% Today?

3 years ago - By: Benzinga - Mentions: MOHO AMWD STSS AHI ...

Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session

3 years ago - By: InvestorPlace - Mentions: MGAM AVCT NBEV INAB ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

3 years ago - By: InvestorPlace - Mentions: HGEN MNMD

Why Is Humanigen (HGEN) Stock Down 16% Today?

3 years ago - By: InvestorPlace - Mentions: AMC HGEN

Dear AMC Stock Fans, Mark Your Calendars for Sept. 3

3 years ago - By: InvestorPlace - Mentions: MNMD

Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting

3 years ago - By: InvestorPlace - Mentions: KPRX VEEE DRUG HIL ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

3 years ago - By: InvestorPlace - Mentions: AGLE SMMT GNS SST ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

3 years ago - By: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction

3 years ago - By: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)

3 years ago - By: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting

4 years ago - By: Clarus Therapeutics Holdings, Inc.

CLARUS THERAPEUTICS HOLDINGS (CRXT) Stock News

CRXT Latest News, Press Relases and Analysis

Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder

Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday

Why Is Pinduoduo (PDD) Stock Up 18% Today?

Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Why Is Humanigen (HGEN) Stock Down 16% Today?

Dear AMC Stock Fans, Mark Your Calendars for Sept. 3

Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction

Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)

Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting

Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate)